NCT00190710 A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00185588 Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00184093 Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00179751 A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas Status TERMINATED Phase PHASE1/PHASE2
NCT00176813 Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00176241 Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer Status TERMINATED Phase PHASE1
NCT00154791 Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00154739 Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00151034 Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer Status COMPLETED Phase PHASE2
NCT00150657 Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer Status UNKNOWN Phase PHASE2
NCT00148395 Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. Status COMPLETED Phase PHASE3
NCT00148135 Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site Status TERMINATED Phase PHASE2
NCT00147875 Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00146276 Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer Status UNKNOWN Phase PHASE3
NCT00142571 Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma Status COMPLETED Phase PHASE3
NCT00142467 Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00136175 Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder Status COMPLETED Phase PHASE2
NCT00134641 Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas Status COMPLETED Phase PHASE2
NCT00128856 Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients Status COMPLETED Phase PHASE2